Literature DB >> 24100200

Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study.

Reza Shafiei1, Mehdi Mohebali2, Behnaz Akhoundi3, Meysam Sharifdini Galian3, Fathollah Kalantar4, Saeedeh Ashkan5, Abdolmajid Fata6, Bibi Razieh Hosseini Farash3, Mehrdad Ghasemian3.   

Abstract

Visceral leishmaniasis (VL) serosurvey was carried out on 49 HIV/AIDS patients among 500 asymptomatic HIV/infected patients who registered in the Khorasan Razavi Province during the last 14 years. HIV infections were detected by ELISA and confirmed using western blot assay at the AIDS centre of the Khorasan Razavi Province. All collected sera were screened using the direct agglutination test (DAT). The sera with anti-Leishmania infantum antibodies at a titre of 1:100 were considered positive for VL infection and serum titration was performed from 1:100 to 1:102,400. Nine (18.4%) patients were sero-positive according to DAT. The distribution of sera titrations were as follows: 1:100 (n = 6) 1:1600 (n = 1); 1:25,600 (n = 1) and 1:102,400 (n = 1). All sero-positive cases showed clinical signs and symptoms. The most predominant signs and symptoms of co-infection of visceral leishmaniasis in HIV-positive patients were pneumonia (n = 2), hepatosplenomegaly (n = 2), lymphadenopathy (n = 2), anaemia (n = 1), prolonged fever (n = 1) and cachexia (n = 1). Our finding shows that VL (or kala-azar) is an opportunistic disease in HIV-positive patients that may be occurred in VL endemic areas of Iran.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV/AIDS; Human; Iran; Visceral leishmaniasis

Mesh:

Year:  2013        PMID: 24100200     DOI: 10.1016/j.tmaid.2013.09.001

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  14 in total

1.  Case Report: First Coinfection Report of Mixed Leishmania infantum/Leishmania major and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran.

Authors:  Alireza Badirzadeh; Mehdi Mohebali; Sadaf Sabzevari; Majid Ghafoori; Kourosh Arzamani; Mohammad Seyyedin; Seyed Ahmad Hashemi
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  Leucocytes and Th-associated Cytokine Profile of HIV-Leishmaniasis Co-Infected Persons Attending Abuja Teaching Hospital, Nigeria.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Habiba Yahaya Muhammad; Abdurrahman El-Fulaty Ahmad; Abubakar Umar Anka; Yusuf Mohammed; Shamsuddeen Haruna; Bamidele Soji Oderinde; Halima Ali Shuwa; Adamu Babayo
Journal:  Eurasian J Med       Date:  2020-10

3.  High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.

Authors:  Z Rezaei; B Sarkari; M Dehghani; A Layegh Gigloo; M Afrashteh
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

4.  Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran.

Authors:  Mohammad Amin Ghatee; Hossein Mirhendi; Mehdi Karamian; Walter R Taylor; Iraj Sharifi; Massood Hosseinzadeh; Zahra Kanannejad
Journal:  Parasitol Res       Date:  2018-08-13       Impact factor: 2.289

5.  Epidemiological Feature of Visceral Leishmaniasis in China, 2004-2012.

Authors:  Shuqing Zhao; Zhongjie Li; Sheng Zhou; Canjun Zheng; Huilai Ma
Journal:  Iran J Public Health       Date:  2015-01       Impact factor: 1.429

6.  Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran.

Authors:  Mohammadali Davarpanah; Masumeh Rassaei; Fatemeh Sari Aslani
Journal:  Case Rep Infect Dis       Date:  2015-05-05

7.  Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.

Authors:  Mohammad Islamuddin; Garima Chouhan; Abdullah Farooque; Bilikere S Dwarakanath; Dinkar Sahal; Farhat Afrin
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

8.  Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013.

Authors:  Fatemeh Heydarpour; Ali Akbari Sari; Mehdi Mohebali; Mohammadreza Shirzadi; Saied Bokaie
Journal:  Ethiop J Health Sci       Date:  2016-07

9.  Molecular identification and polymorphism determination of cutaneous and visceral leishmaniasis agents isolated from human and animal hosts in Iran.

Authors:  Homa Hajjaran; Mehdi Mohebali; Setareh Mamishi; Farzaneh Vasigheh; Mohammad Ali Oshaghi; Saied Reza Naddaf; Aref Teimouri; Gholam Hossein Edrissian; Zabiholah Zarei
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

10.  Prevalence and risk factors associated with Leishmania infection in Trang Province, southern Thailand.

Authors:  Jipada Manomat; Saovanee Leelayoova; Lertwut Bualert; Peerapan Tan-Ariya; Suradej Siripattanapipong; Mathirut Mungthin; Tawee Naaglor; Phunlerd Piyaraj
Journal:  PLoS Negl Trop Dis       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.